In addition to the downstream gene regulatory networks, our recent observation that IRF4 is activated through Src-mediated tyrosine phosphorylation in EBV-associated lymphomas [69], represents another important topic and a novel challenge for studying the interaction of IRF4 with hematological malignancies. Here, IRF4 is linked to lymphoma.